Quoin Pharmaceuticals Ltd...

NASDAQ: QNRX · Real-Time Price · USD
7.50
0.20 (2.67%)
At close: Aug 15, 2025, 3:34 PM
7.48
-0.20%
After-hours: Aug 15, 2025, 04:04 PM EDT

Quoin Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-12.17M -10.44M -8.98M -8.74M -8.32M -8.46M -8.71M -8.64M -9.74M -10.3M -9.38M -19.2M -17.57M -19.24M -21.46M -10.66M -9.59M -5.6M
Depreciation & Amortization
100.01K 99.92K 99.92K 100.67K 101.87K 102.97K 103.98K 104.04K 104.04K 104.04K 104.04K 104.04K 104.04K 104.04K 104.04K 104.04K 104.04K 104.04K
Stock-Based Compensation
1.32M 1.31M 1.26M 1.23M 1.19M 1.14M 1.09M 1.06M 1.06M 1.03M 763.57K 496.28K 229K n/a n/a n/a n/a n/a
Other Working Capital
264.49K -71.83K -280.73K -76.56K -290.19K -47.1K -648.22K -650.3K -171.66K -355.88K 123.45K -16.16K -361.27K -141.43K -18.68K 563.32K 266.64K 64.13K
Other Non-Cash Items
-280.62K -219.93K -231.37K 1.07M 999.57K 925.37K 870.25K -139.5K 389.55K 716.12K 356.51K 8.39M 7.85M 10.78M 14.31M 6.43M 6.62M 3.57M
Deferred Income Tax
n/a n/a n/a -1.34M -1.34M -1.34M -1.34M n/a n/a -229 -229 -229 -229 n/a n/a n/a n/a n/a
Change in Working Capital
332.26K 232.25K -1.54K -1.17M -617.27K 76.95K 113.71K 1.03M 631.47K 551.85K -94.35K 721.03K 1.29M 957.98K 1.33M 1.05M 480.85K 547.47K
Operating Cash Flow
-10.7M -9.01M -7.86M -8.84M -7.98M -7.55M -7.86M -6.58M -7.56M -8.13M -8.48M -9.72M -8.33M -7.4M -5.72M -3.08M -2.43M -1.43M
Capital Expenditures
3.27 n/a 4.43 4.43 4.43 4.43 n/a 250K 251.64K 51.64K 1.64K -498.36K -607.5K -532.5K -625K -375K -267.5K -142.5K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-7.6M -7.54M -17.19M -11.37M -14.36M -14.42M -18.26M -18.15M -23.34M -23.35M -9.86M -9.79M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
7.2M 13.1M 15.34M 15.33M 15.73M 15.63M 20.45M 17.64M 13.04M 10M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
4.28M -219.57K -46.61K -46.61K -44.29K -9.8K -13.3K -10.14B -10.14B -10.14B -10.14B -407.33K -407.7K -266.48K -357.5K -232.5K -125K -266.02K
Investing Cash Flow
3.88M 5.35M -1.89M 3.92M 1.32M 1.2M 2.18M -10.14B -10.15B -10.15B -10.15B -10.4M -607.5K -532.5K -625K -500K -392.5K -267.5K
Debt Repayment
-450K -600K -600K -600K -725K -575K -425K -275K n/a n/a n/a n/a n/a 2.06M 3.48M 4.38M 4.38M 2.32M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a -65.27M -65.27M -65.27M -65.27M n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-181.98K -31.52K -93.24K -144.02K -136.87K -212.34K 5.6M 5.17M 19.91M 19.83M 13.93M 24.71M 9.91M 9.98M 10.03M -147.79K 158.09K 454.63K
Financial Cash Flow
5.64M 5.62M 10.93M 4.83M 4.7M 4.8M 5.22M 4.95M 19.98M 19.91M 14.01M 24.71M 9.91M 12.04M 13.5M 4.24M 4.54M 2.77M
Net Cash Flow
-1.18M 1.99M 1.22M -46.63K -1.91M -1.54M -459.37K -2.09M 2.07M -1.82M -4.62M 4.6M 967.47K 4.11M 7.16M 652.79K 1.72M 1.08M
Free Cash Flow
-10.7M -9.01M -7.87M -8.9M -8.04M -7.61M -7.9M -6.33M -7.3M -8.08M -8.48M -10.22M -8.94M -7.93M -6.35M -3.46M -2.7M -1.57M